Revvity Inc. (RVTY) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Revvity, Inc. provides health sciences solutions, technologies, and services.

Total Assets Chart for Revvity Inc.

Revvity Inc. (RVTY) total assets for FY2025 were USD 12.2B, a -1.8% change from FY2024. Revvity Inc.'s total assets grew from USD 429.8M in 1985 to USD 12.2B in 2025 (2731.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 8.9%, 10-year CAGR of 11.3%, 20-year CAGR of 7.8%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$12.74B
Implied Share Price
$114.24
Enterprise Value
$14.92B
Revenue (TTM)
$2.91B
EBITDA
$866.87M
Profit Margin
8.16%
Trailing P/E
55.19
Forward P/E
21.28
Price/Book (MRQ)
1.73
Price/Sales (TTM)
4.38
EV/EBITDA
19.30
EV/Revenue
5.14
Dividend Yield
0.12%
Book Value
$64.76
Free Cash Flow (FY2025)
$508.25M
Free Cash Flow Yield
3.99%

Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.